Esposito M, Worthington H V, Thomsen P, Coulthard P
Department of Biomaterials and Department of Prosthetic Dentistry/Dental Material Sciences, Sahlgrenska Academy at Goteborg University, PO Box 412, Medicinaregatan 8B, Goteborg, Sweden.
Cochrane Database Syst Rev. 2003(3):CD004151. doi: 10.1002/14651858.CD004151.
Dental implants are used for replacing missing teeth. However, the possibility of placing dental implants is limited by the presence of adequate bone volume permitting their anchorage. Several bone grafting procedures have been developed to solve this problem. The missing bone can be taken from a donor site, transplanted where needed and then implants are placed. Major bone grafting operations have to be undertaken under general anaesthesia and patients have to be hospitalized for a few days. Some degree of morbidity related to the donor site must be expected and two to three surgical interventions are needed before the implants can be functionally used. Often patients have to wait more than 1 year before a denture can be fixed to the implants and the total cost of the treatment is high. However, the major problem is that about 25% of the implants placed in grafted bone fail. Zygomatic implants are long screw-shaped implants developed as an alternative to bone grafting. Zygomatic implants are inserted into the body of the zygomatic bone. Their main advantages are that bone grafting may not be needed and patients may be fitted with a fixed denture much sooner.
To test the hypothesis of no difference in outcomes between zygomatic implants without bone augmenting procedures in comparison with conventional dental implants in augmented bone for severely resorbed maxillae.
We searched the Cochrane Oral Health Group's Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and EMBASE. We handsearched several dental journals. No language restrictions were applied. Personal contacts and manufacturers of dental implants were contacted to identify unpublished trials. Most recent search: February 2003.
Randomised controlled clinical trials (RCTs) on patients with severely resorbed maxillae who could not be rehabilitated with conventional dental implants, treated with zygomatic implants without bone grafts versus conventional dental implants with bone grafts or other procedures for bone augmentation with a follow up of at least 1 year. Outcome measures considered were: prosthesis and implant failures, side effects, patient satisfaction and cost effectiveness.
Screening of eligible studies, assessment of the methodological quality of the trials and data extraction were to be conducted in duplicate and independently by two reviewers. Results were to be expressed as random effects models using weighted mean differences for continuous outcomes and relative risk for dichotomous outcomes with 95% confidence interval. Heterogeneity was to be investigated including both clinical and methodological factors.
No RCTs or controlled clinical trials (CCTs) were identified.
REVIEWER'S CONCLUSIONS: There is an urgent need for RCTs in this area, since zygomatic implants, if found to be at least as effective as other augmentation procedures, may involve major advantages for both patients and society.
牙种植体用于替代缺失牙。然而,植入牙种植体的可能性受到允许其锚固的足够骨量的限制。已经开发了几种骨移植程序来解决这个问题。缺失的骨可以从供体部位获取,移植到需要的地方,然后植入种植体。主要的骨移植手术必须在全身麻醉下进行,患者必须住院几天。必须预料到与供体部位相关的一定程度的发病率,并且在种植体能够发挥功能使用之前需要两到三次手术干预。患者通常必须等待超过1年才能将假牙固定在种植体上,并且治疗的总成本很高。然而,主要问题是植入移植骨中的种植体约有25%会失败。颧骨种植体是作为骨移植的替代方法而开发的长螺旋形种植体。颧骨种植体插入颧骨体。它们的主要优点是可能不需要骨移植,并且患者可能更快地安装固定假牙。
检验在严重吸收的上颌骨中,不进行骨增量程序的颧骨种植体与常规牙种植体在增量骨中的效果无差异的假设。
我们检索了Cochrane口腔健康组试验注册库、Cochrane对照试验中央注册库(CENTRAL)、MEDLINE和EMBASE。我们手工检索了几本牙科杂志。未应用语言限制。联系了个人联系人及牙种植体制造商以识别未发表的试验。最近一次检索:2003年2月。
对严重吸收的上颌骨患者进行的随机对照临床试验(RCT),这些患者不能用常规牙种植体修复,接受无骨移植的颧骨种植体治疗与接受有骨移植的常规牙种植体或其他骨增量程序治疗,随访至少1年。考虑的结局指标为:假体和种植体失败、副作用、患者满意度和成本效益。
由两名评价员独立重复进行合格研究的筛选、试验方法学质量的评估和数据提取。结果将以随机效应模型表示,连续结局使用加权均数差,二分结局使用相对危险度,并给出95%置信区间。将调查异质性,包括临床和方法学因素。
未识别到RCT或对照临床试验(CCT)。
该领域迫切需要RCT,因为如果发现颧骨种植体至少与其他增量程序一样有效,可能对患者和社会都有重大益处。